Clincosm LogoSign in Get a demo

Neuroblastoma

Showing NaN - NaN of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

Recruiting
  • Neuroblastoma
  • +2 more
  • OPT-821 (QS-21)
  • oral β-glucan
  • Basking Ridge, New Jersey
  • +6 more
Sep 21, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Genomic Structural Variation in Cancer Susceptibility

Active, not recruiting
  • Breast Cancer
  • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 23, 2022

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Neuroblastoma Trial in New York (dietary supplement, drug, biological)

    Recruiting
    • Neuroblastoma
    • β-glucan
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 5, 2022

    Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

    Active, not recruiting
    • Melanoma
    • +2 more
    • 124I-Humanized 3F8
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 1, 2022

    Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

    Recruiting
    • Ganglioneuroblastoma
    • Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +18 more
    • Birmingham, Alabama
    • +158 more
    Sep 14, 2022

    Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)

    Recruiting
    • Neuroblastoma
    • GM-CSF + Naxitamab
    • Gainesville, Florida
    • +22 more
    Aug 29, 2022

    Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

    Recruiting
    • Ewing Sarcoma
    • +6 more
    • Birmingham, Alabama
    • +83 more
    Aug 19, 2022

    Neuroblastoma Trial in United States (18F-MFBG)

    Recruiting
    • Neuroblastoma
    • Los Angeles, California
    • +7 more
    Aug 18, 2022

    Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

    Active, not recruiting
    • Ganglioneuroblastoma, Nodular
    • Neuroblastoma
    • Dinutuximab
    • +4 more
    • Mesa, Arizona
    • +77 more
    Aug 17, 2022

    Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,

    Recruiting
    • Ganglioneuroblastoma
    • +3 more
    • Birmingham, Alabama
    • +219 more
    Aug 17, 2022

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)

    Terminated
    • Neuroblastoma
    • +2 more
    • Humanized 3F8 Bispecific Antibody
    • Blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 11, 2022

    Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma Trial in United States (67Cu-SARTATE, 64Cu-SARTATE)

    Recruiting
    • Neuroblastoma
    • +2 more
    • Phoenix, Arizona
    • +8 more
    Jun 29, 2022

    Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

    Active, not recruiting
    • Neuroblastoma
    • Hu3F8
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 1, 2022

    Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

    Completed
    Has Results
    • Neuroblastoma
    • anti-GD2 murine IgG3 monoclonal antibody 3F8
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Apr 21, 2022

    Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

    Active, not recruiting
    • Neuroblastoma
    • Hu3F8 With GM-CSF
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 2, 2022

    Neuroblastoma Trial in New York (beta-glucan, mAb 3F8, immunohistochemistry staining method)

    Completed
    • Neuroblastoma
    • beta-glucan
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 4, 2022

    Neuroblastoma, High-Risk Trial in New York (cyclophosphamide, NK cells, hu3F8)

    Active, not recruiting
    • Neuroblastoma
    • High-Risk
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 14, 2022

    Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)

    Recruiting
    • Neuroblastoma
    • +2 more
    • 131I-omburtamab
    • Los Angeles, California
    • +11 more
    Dec 17, 2021

    Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

    Recruiting
    • Pediatric Solid Tumor
    • +7 more
    • CLR 131
    • Palo Alto, California
    • +6 more
    Nov 30, 2021